Immunity beyond cancer cells: perspective from tumor tissue

Area of Science:

• Immunology
• Cancer Biology
• Oncology

Background:

• Cancer is increasingly viewed as a cell-level disease, leading to targeted therapies like T cell-based immunotherapy.
• Many patients remain unresponsive to current cancer treatments, and acquired resistance is common.
• The tumor microenvironment significantly influences cancer cell behavior and treatment efficacy.

Purpose of the Study:

• To explore the role of Helper T (Th) cells in orchestrating immune responses against cancer.
• To investigate the potential of Th2 cells as anticancer effectors by examining their role in tumor microenvironment modulation.
• To evaluate the feasibility of harnessing Th cell-mediated immunity for novel cancer immunotherapy strategies.

Main Methods:

• Review of recent studies on Th cell subsets (Th1 and Th2) in cancer immunity.
• Analysis of the mechanisms by which Th2 cells influence tumor stroma and tissue repair.
• Conceptual framework for developing tissue-level immunotherapies targeting the cancer environment.

Main Results:

• While Th1 cells produce interferon-gamma (IFN-γ) for direct cancer cell targeting, Th2 cells produce interleukin-4 (IL-4).
• Th2 cells demonstrate potent anticancer effects through tumor stroma reconfiguration and tissue repair.
• Th cell activity extends beyond direct cytotoxicity to influencing the broader tumor ecosystem.

Conclusions:

• Helper T cells, particularly Th2 cells, play a crucial role in anti-cancer immunity.
• Th2 cell-induced modulation of the tumor microenvironment offers a promising avenue for cancer treatment.
• Harnessing Th cell-mediated tissue-level immunity could lead to innovative cancer immunotherapies.